Found: 20
Select item for more details and to access through your institution.
<sup>111</sup>In- and <sup>203</sup>Pb-labeled cyclic arginine-glycine-aspartic acid peptide conjugate as an α<sub>v</sub>β<sub>3</sub> integrin-binding radiotracer.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2012, v. 55, n. 11, p. 423, doi. 10.1002/jlcr.2965
- By:
- Publication type:
- Article
Antibody-targeted radiation cancer therapy.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 6, p. 488, doi. 10.1038/nrd1413
- By:
- Publication type:
- Article
In Vivo Tumor Targeting of a Recombinant Single-Chain Antigen-Binding Protein.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 14, p. 1191, doi. 10.1093/jnci/82.14.1191
- By:
- Publication type:
- Article
Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 435, doi. 10.3390/ph8030435
- By:
- Publication type:
- Article
Toxicological Studies of <sup>212</sup>Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 416, doi. 10.3390/ph8030416
- By:
- Publication type:
- Article
Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 435, doi. 10.3390/ph8030435
- By:
- Publication type:
- Article
Toxicological Studies of <sup>212</sup>Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 416, doi. 10.3390/ph8030416
- By:
- Publication type:
- Article
Pre-Clinical Assessment of <sup>177</sup>Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease.
- Published in:
- Pharmaceuticals (14248247), 2012, v. 5, n. 1, p. 1, doi. 10.3390/ph5010001
- By:
- Publication type:
- Article
Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from 177Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 5, p. 736, doi. 10.3390/ijms17050736
- By:
- Publication type:
- Article
Impact of α-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0108511
- By:
- Publication type:
- Article
HER1-Targeted <sup>86</sup>Y-Panitumumab Possesses Superior Targeting Characteristics than <sup>86</sup>Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0018198
- By:
- Publication type:
- Article
Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates.
- Published in:
- Cancer (0008543X), 1994, v. 73, n. S3, p. 993, doi. 10.1002/1097-0142(19940201)73:3+<993::AID-CNCR2820731337>3.0.CO;2-7
- By:
- Publication type:
- Article
PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1-Targeted <sup>89</sup>Zr-Labeled Panitumumab.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 1, p. 113, doi. 10.2967/jnumed.111.094169
- By:
- Publication type:
- Article
Preparation, Biological Evaluation, and Pharmacokinetics of the Human Anti-HER1 Monoclonal Antibody Panitumumab Labeled with <sup>86</sup>Y for Quantitative PET of Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 6, p. 942, doi. 10.2967/jnumed.109.071290
- By:
- Publication type:
- Article
PET imaging of tumor angiogenesis in mice with VEGF-A-targeted.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 4, p. 920, doi. 10.1002/ijc.25409
- By:
- Publication type:
- Article
Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and <sup>212</sup>Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0159904
- By:
- Publication type:
- Article
Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Improved Efficacy of α-Particle–Targeted Radiation Therapy.
- Published in:
- Cancer (0008543X), 2010, v. 116, p. 1059
- By:
- Publication type:
- Article
Assay for the detection of anti-idiotypic antibodies to monoclonal antibody B72.3.
- Published in:
- 1990
- By:
- Publication type:
- journal article
In Vivo Fate of Monoclonal Antibody B72.3 in Patients with Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 1990, v. 31, n. 7, p. 1133
- By:
- Publication type:
- Article